HIMS & HERS HEALTH INC (HIMS)
US4330001060 - Common Stock
Taking everything into account, HIMS scores 5 out of 10 in our fundamental rating. HIMS was compared to 113 industry peers in the Health Care Providers & Services industry. While HIMS has a great health rating, its profitability is only average at the moment. HIMS is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
HIMS had positive earnings in the past year.
In the past year HIMS had a positive cash flow from operations.
HIMS had negative earnings in 4 of the past 5 years.
In the past 5 years HIMS reported 4 times negative operating cash flow.
1.2 Ratios
HIMS's Return On Assets of 16.81% is amongst the best of the industry. HIMS outperforms 98.23% of its industry peers.
The Return On Equity of HIMS (23.01%) is better than 92.92% of its industry peers.
HIMS has a Return On Invested Capital of 7.74%. This is in the better half of the industry: HIMS outperforms 78.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.81% | ||
| ROE | 23.01% | ||
| ROIC | 7.74% |
ROA(3y)-16.29%
ROA(5y)-9.96%
ROE(3y)-20.03%
ROE(5y)-12.22%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 8.15%, HIMS belongs to the top of the industry, outperforming 90.27% of the companies in the same industry.
HIMS has a Operating Margin (3.55%) which is in line with its industry peers.
HIMS's Gross Margin of 81.13% is amongst the best of the industry. HIMS outperforms 93.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.55% | ||
| PM (TTM) | 8.15% | ||
| GM | 81.13% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HIMS is destroying value.
HIMS has more shares outstanding than it did 1 year ago.
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
HIMS has an Altman-Z score of 20.78. This indicates that HIMS is financially healthy and has little risk of bankruptcy at the moment.
HIMS has a Altman-Z score of 20.78. This is amongst the best in the industry. HIMS outperforms 98.23% of its industry peers.
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 20.78 |
ROIC/WACC0.87
WACC8.9%
2.3 Liquidity
A Current Ratio of 2.14 indicates that HIMS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.14, HIMS is in the better half of the industry, outperforming 78.76% of the companies in the same industry.
HIMS has a Quick Ratio of 1.82. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
HIMS has a better Quick ratio (1.82) than 71.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.14 | ||
| Quick Ratio | 1.82 |
3. Growth
3.1 Past
HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 205.88%, which is quite impressive.
Looking at the last year, HIMS shows a very strong growth in Revenue. The Revenue has grown by 56.70%.
EPS 1Y (TTM)205.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
Revenue 1Y (TTM)56.7%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%77.13%
3.2 Future
The Earnings Per Share is expected to grow by 71.62% on average over the next years. This is a very strong growth
Based on estimates for the next years, HIMS will show a very strong growth in Revenue. The Revenue will grow by 20.08% on average per year.
EPS Next Y314.2%
EPS Next 2Y130.31%
EPS Next 3Y91.33%
EPS Next 5Y71.62%
Revenue Next Year59.89%
Revenue Next 2Y46.59%
Revenue Next 3Y36.34%
Revenue Next 5Y20.08%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 130.11, which means the current valuation is very expensive for HIMS.
HIMS's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of HIMS to the average of the S&P500 Index (28.76), we can say HIMS is valued expensively.
With a Price/Forward Earnings ratio of 64.43, HIMS can be considered very expensive at the moment.
HIMS's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of HIMS to the average of the S&P500 Index (23.90), we can say HIMS is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 130.11 | ||
| Fwd PE | 64.43 |
4.2 Price Multiples
HIMS's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, HIMS is valued a bit cheaper than 69.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 33.88 | ||
| EV/EBITDA | 81.88 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HIMS's earnings are expected to grow with 91.33% in the coming years.
PEG (NY)0.41
PEG (5Y)N/A
EPS Next 2Y130.31%
EPS Next 3Y91.33%
5. Dividend
5.1 Amount
No dividends for HIMS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HIMS & HERS HEALTH INC
NYSE:HIMS (11/6/2024, 8:04:00 PM)
Premarket: 23.3 -0.12 (-0.51%)23.42
+2.78 (+13.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.07B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 130.11 | ||
| Fwd PE | 64.43 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.41
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.81% | ||
| ROE | 23.01% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 3.55% | ||
| PM (TTM) | 8.15% | ||
| GM | 81.13% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.06
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.14 | ||
| Quick Ratio | 1.82 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)205.88%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y314.2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)56.7%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y